Effects of prostacyclin on fetal platelet function

Area of Science:

• Cardiovascular Physiology
• Fetal Medicine
• Endocrinology

Background:

• Prostacyclin (PGI2) is a key metabolite of arachidonic acid in vascular endothelium.
• PGI2 exhibits antiaggregatory and vasodilator properties, crucial for vascular homeostasis.
• The role of PGI2 in fetal circulation and platelet function requires further elucidation.

Purpose of the Study:

• To investigate the significance of PGI2 on fetal platelets.
• To compare PGI2 levels and related factors in maternal and umbilical cord blood.
• To assess the impact of pre-eclampsia on PGI2 generation in fetal circulation.

Main Methods:

• Measurement of platelet aggregation induced by ADP, collagen, and adrenaline.
• Quantification of plasma beta-thromboglobulin, 6-keto-PGF1 alpha, TxB2, cyclic AMP, and cyclic GMP.
• Assay of PGI2-like substance release from umbilical and placental tissues.

Main Results:

• Platelet aggregation was augmented in maternal blood but suppressed in umbilical cord blood.
• Plasma levels of beta-thromboglobulin, 6-keto-PGF1 alpha, TxB2, cyclic AMP, and cyclic GMP were elevated in umbilical cord blood.
• Reduced PGI2-like substance generation was observed in umbilical vessels of patients with severe pre-eclampsia and intrauterine fetal growth retardation.

Conclusions:

• Fetal blood exhibits high levels of PGI2, TxA2, and cyclic nucleotides, necessitating a balance for vascular health.
• PGI2 is vital for maintaining platelet-vascular wall interactions and regulating placental-fetal circulation.
• Impaired PGI2 generation in pre-eclampsia may contribute to intrauterine fetal growth retardation.